title: Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis.
abstract: A rapid and accurate method to detect and quantify Leishmania parasite is urgently needed to facilitate early diagnosis of leishmaniasis and monitoring of antileishmania therapy. In this study, real-time assay was applied to estimate parasite load in clinical samples of visceral leishmaniasis (VL) and post kala-azar dermal leishmaniasis (PKDL) patients. The mean parasite load in blood of VL patients (n = 31) was 8,372 parasites/ml, while the mean parasite load in bone marrow aspirate (BMA) was 194,962 parasites/million nucleated cells (n = 12). Parasite load was undetectable after treatment with amphotericin B (n = 9) in VL, while a residual parasite burden was detected in 2 of 6 patients following treatment with sodium antimony gluconate. Further, circulating levels of IFN-gamma, TNF-alpha, IL-10, IL-6, IL-4 and IL-2 were analysed in VL patients (n = 29) by Cytometric Bead Array to evaluate correlation with parasitic load. Interestingly, IL-10 levels correlated significantly with parasite load (r = 0.82, P<0.0001). The mean parasite load in dermal lesions of PKDL patients was 9,502 parasites/microg tissue DNA at pre-treatment stage (n = 25), with no detectable parasites after therapy (n = 5). Parasite burden was distinctly higher (P<0.0001) in nodular lesions (n = 12) (19,586 parasites/microg tissue DNA) compared to papular/macular lesions (n = 13, 193 parasites/microg tissue DNA). Further, chronic PKDL lesions showed significantly (P = 0.0166) higher parasite load in comparison with acute lesions. Results indicate that chronic, nodular cases constitute the major parasite reservoir for anthroponotic transmission. Our results establish that the high parasite load in VL is strongly correlated with a high level of IL-10, implicating IL-10 as a marker of disease severity. The assay is applicable for diagnosis as well as prognosis of both VL and PKDL, providing a simple molecular tool to monitor the efficacy of antileishmanial drugs or vaccines.
authors.affiliation: Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delhi, India.
authors.forename: Sandeep
authors.initials: S
authors.lastname: Verma
authors.forename: Rajesh
authors.initials: R
authors.lastname: Kumar
authors.forename: Gajendra Kumar
authors.initials: GK
authors.lastname: Katara
authors.forename: Laishram Chandreshwor
authors.initials: LC
authors.lastname: Singh
authors.forename: Narender Singh
authors.initials: NS
authors.lastname: Negi
authors.forename: V
authors.initials: V
authors.lastname: Ramesh
authors.forename: Poonam
authors.initials: P
authors.lastname: Salotra
mesh_terms: D015415:Biomarkers / Q000097:blood; D001769:Blood / Q000469:parasitology; D001853:Bone Marrow / Q000469:parasitology; D016054:DNA, Protozoan / Q000097:blood; D006801:Humans; D016753:Interleukin-10 / Q000097:blood*; D007891:Leishmania / Q000254:growth & development / Q000302:isolation & purification*; D007896:Leishmaniasis / Q000175:diagnosis*; D016773:Leishmaniasis, Cutaneous / Q000175:diagnosis; D007898:Leishmaniasis, Visceral / Q000175:diagnosis; D016133:Polymerase Chain Reaction; D012720:Severity of Illness Index
chemical_list: D015415:Biomarkers; D016054:DNA, Protozoan; D016753:Interleukin-10
references.citation: J Clin Microbiol. 2001 Mar;39(3):849-54
references.pmid: 11230394
references.citation: Am J Trop Med Hyg. 2007 May;76(5):896-901
references.pmid: 17488912
references.citation: Cytokine. 1995 Oct;7(7):740-5
references.pmid: 8580385
references.citation: Infect Immun. 1995 Mar;63(3):1130-3
references.pmid: 7868238
references.citation: Infect Immun. 1994 Mar;62(3):1058-63
references.pmid: 8112840
references.citation: J Infect Dis. 2006 Oct 1;194(7):958-65
references.pmid: 16960784
references.citation: J Clin Microbiol. 2004 Mar;42(3):1214-9
references.pmid: 15004078
references.citation: J Clin Invest. 1993 Jul;92(1):324-9
references.pmid: 8326000
references.citation: Clin Immunol. 2006 Jun;119(3):339-45
references.pmid: 16540374
references.citation: Clin Exp Immunol. 2006 Oct;146(1):124-32
references.pmid: 16968407
references.citation: J Clin Microbiol. 2004 Nov;42(11):5249-55
references.pmid: 15528722
references.citation: J Immunol. 1995 Jul 15;155(2):722-9
references.pmid: 7608550
references.citation: J Immunol. 1994 Apr 1;152(7):3514-21
references.pmid: 7908304
references.citation: Rev Inst Med Trop Sao Paulo. 1998 Jan-Feb;40(1):31-4
references.pmid: 9713135
references.citation: Trans R Soc Trop Med Hyg. 2001 May-Jun;95(3):239-43
references.pmid: 11490989
references.citation: J Clin Microbiol. 2001 Jun;39(6):2065-71
references.pmid: 11376036
references.citation: Transfusion. 2008 Sep;48(9):1787-98
references.pmid: 18564397
references.citation: Trans R Soc Trop Med Hyg. 2000 Mar-Apr;94(2):200-4
references.pmid: 10897369
references.citation: J Immunol. 1993 Nov 15;151(10):5425-30
references.pmid: 8228235
references.citation: J Immunol. 1995 Mar 15;154(6):2668-77
references.pmid: 7533180
references.citation: Trop Med Int Health. 2007 Jul;12(7):848-51
references.pmid: 17596251
references.citation: Acta Trop. 2007 Sep;103(3):195-200
references.pmid: 17662227
references.citation: J Clin Microbiol. 2002 May;40(5):1666-9
references.pmid: 11980939
references.citation: J Exp Med. 2001 Nov 19;194(10):1497-506
references.pmid: 11714756
references.citation: FEMS Immunol Med Microbiol. 2009 Dec;57(3):239-46
references.pmid: 19799628
references.citation: J Immunol. 1992 Mar 15;148(6):1792-6
references.pmid: 1541819
references.citation: Trans R Soc Trop Med Hyg. 2002 Apr;96 Suppl 1:S179-83
references.pmid: 12055835
references.citation: Clin Infect Dis. 2000 Oct;31(4):1104-7
references.pmid: 11049798
references.citation: J Infect Dis. 1993 Oct;168(4):986-93
references.pmid: 8376845
references.citation: Clin Immunol Immunopathol. 1995 Oct;77(1):111-4
references.pmid: 7554475
references.citation: Cytokine. 2008 Nov;44(2):288-92
references.pmid: 18842424
references.citation: J Clin Microbiol. 1998 Jul;36(7):1989-95
references.pmid: 9650950
references.citation: J Immunol. 1991 Nov 1;147(9):3149-55
references.pmid: 1833466
references.citation: Trans R Soc Trop Med Hyg. 1993 Jan-Feb;87(1):94-6
references.pmid: 8465412
references.citation: Am J Trop Med Hyg. 2005 Dec;73(6):999-1004
references.pmid: 16354801
references.citation: J Parasitol. 2004 Oct;90(5):1150-4
references.pmid: 15562617
references.citation: Am J Trop Med Hyg. 2004 Nov;71(5):561-7
references.pmid: 15569785
references.citation: Br J Dermatol. 2000 Jul;143(1):136-43
references.pmid: 10886148
references.citation: J Clin Invest. 1993 Apr;91(4):1644-8
references.pmid: 8097208
references.citation: J Clin Pathol. 2003 Nov;56(11):840-3
references.pmid: 14600129
references.citation: Res Vet Sci. 2009 Aug;87(1):76-8
references.pmid: 19178919
references.citation: J Immunol. 1992 Feb 15;148(4):1143-8
references.pmid: 1737931
references.citation: Ann Trop Med Parasitol. 1992 Aug;86(4):355-9
references.pmid: 1463355
references.citation: Clin Diagn Lab Immunol. 2001 Jul;8(4):828-31
references.pmid: 11427436
references.citation: BMC Infect Dis. 2005 Dec 19;5:113
references.pmid: 16364177
references.citation: Vet Immunol Immunopathol. 2009 Apr 15;128(4):349-58
references.pmid: 19124159
references.citation: J Clin Microbiol. 2003 Nov;41(11):5080-4
references.pmid: 14605142
references.citation: J Mol Diagn. 2005 May;7(2):268-75
references.pmid: 15858151
references.citation: J Immunol. 1994 Oct 1;153(7):3135-40
references.pmid: 8089491